Hepatocellular carcinoma: Iodized-oil CT TNM classification

被引:25
作者
Valls, C
Figueras, J
Jaurrieta, E
Sancho, C
Dominguez, J
Benasco, C
Moreno, P
Rafecas, A
Virgili, J
Castellsague, X
机构
[1] CIUTAT SANITARIA & UNIV BELLVITGE,DEPT RADIOL,E-08907 LHOSPITALET LLOBR,BARCELONA,SPAIN
[2] CIUTAT SANITARIA & UNIV BELLVITGE,LIVER TRANSPLANT UNIT,E-08907 LHOSPITALET LLOBR,BARCELONA,SPAIN
[3] CIUTAT SANITARIA & UNIV BELLVITGE,DEPT PATHOL,E-08907 LHOSPITALET LLOBR,BARCELONA,SPAIN
[4] CIUTAT SANITARIA & UNIV BELLVITGE,DEPT CANC EPIDEMIOL,E-08907 LHOSPITALET LLOBR,BARCELONA,SPAIN
关键词
D O I
10.2214/ajr.167.2.8686630
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. We conducted a prospective study to determine the efficacy of iodized-oil enhancement in CT for preoperative assessment of the T factor of the TNM classification in patients with hepatocellular carcinoma (HCC). SUBJECTS AND METHODS. Iodized-oil CT was performed as a part of preoperative staging in 28 patients with HCC. We determined the radiologic T factor, Pathologic correlation was obtained after orthotopic liver transplantation (n = 25) or autopsy (n = 3), and the histologic T factor was determined. RESULTS. The sensitivity of iodized-oil CT for accurately distinguishing between stage-T4 tumors and tumors in stages T1-T3 was 88% (7/8) with a positive predictive value of 100% (7/7). CONCLUSION. Iodized-oil CT is useful for preoperatively assessing the T factor of the TNM classification in HCC, and it improves the accuracy of radiologic staging. Iodized-oil CT can help to better select patients with HCC for orthotopic liver transplantation.
引用
收藏
页码:477 / 481
页数:5
相关论文
共 34 条
[1]   UNDERSTANDING AND OPTIMIZING USE OF CONTRAST MATERIAL FOR CT OF THE LIVER [J].
BARON, RL .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1994, 163 (02) :323-331
[2]   INTRAHEPATIC RECURRENCE AFTER RESECTION OF HEPATOCELLULAR-CARCINOMA COMPLICATING CIRRHOSIS [J].
BELGHITI, J ;
PANIS, Y ;
FARGES, O ;
BENHAMOU, JP ;
FEKETE, F .
ANNALS OF SURGERY, 1991, 214 (02) :114-117
[3]   PRIMARY-TREATMENT OF HEPATOCELLULAR-CARCINOMA BY ARTERIAL CHEMOEMBOLIZATION [J].
BISMUTH, H ;
MORINO, M ;
SHERLOCK, D ;
CASTAING, D ;
MIGLIETTA, C ;
CAUQUIL, P ;
ROCHE, A .
AMERICAN JOURNAL OF SURGERY, 1992, 163 (04) :387-394
[4]  
BUFFET C, 1990, ANN GASTROENT HEPATO, V26, P299
[5]  
CHERQUI D, 1994, CANCER, V73, P2721, DOI 10.1002/1097-0142(19940601)73:11<2721::AID-CNCR2820731112>3.0.CO
[6]  
2-K
[7]   PROGRESS IN ORTHOTOPIC LIVER-TRANSPLANTATION FOR HEPATOCELLULAR-CARCINOMA [J].
GORES, GJ ;
STEERS, JL .
GASTROENTEROLOGY, 1993, 104 (01) :317-320
[8]  
GORES GJ, 1993, GASTROENTEROL CLIN N, V22, P285
[9]   HEPATOCELLULAR-CARCINOMA - PROSPECTIVE ASSESSMENTS OF THE T-FACTOR WITH CT, US, AND MR-IMAGING [J].
HONDA, H ;
ONITSUKA, H ;
ADACHI, E ;
OCHIAI, K ;
GIBO, M ;
YASUMORI, K ;
MATSUMATA, T ;
SUGIMACHI, K ;
MASUDA, K .
ABDOMINAL IMAGING, 1993, 18 (03) :247-252
[10]   HEPATIC RESECTION VERSUS TRANSPLANTATION FOR HEPATOCELLULAR-CARCINOMA [J].
IWATSUKI, S ;
STARZL, TE ;
SHEAHAN, DG ;
YOKOYAMA, I ;
DEMETRIS, AJ ;
TODO, S ;
TZAKIS, AG ;
VANTHIEL, DH ;
CARR, B ;
SELBY, R ;
MADARIAGA, J .
ANNALS OF SURGERY, 1991, 214 (03) :221-229